Previous 10 | Next 10 |
Gainers: AgriFORCE Growing Systems (NASDAQ:AGRI) +159%. Arcadia Biosciences (NASDAQ:RKDA) +44%. CEA Industries (NASDAQ:CEAD) +32%. Enservco (NYSE:ENSV) +30%. Ebix (NASDAQ:EBIX) +27%. Pop Culture Group (NASDAQ:CPOP) +26%. Natera (NASDAQ:NTRA) +24%. Kala Pharmaceuticals (NASDAQ:KALA) +21%. iPow...
Asana (NYSE:ASAN) -26% on Q4 earnings release. ACM Research (NASDAQ:ACMR) -17%. Sunshine Biopharma (NASDAQ:SBFM) -16%. Revelation Biosciences (NASDAQ:REVB) -15%. I-Mab (NASDAQ:IMAB) -14%. Sentage Holdings (NASDAQ:SNTG) -14%. Build-A-Bear Workshop (NYSE:BBW) -13% on Q4 earn...
Neximmune press release (NASDAQ:NEXI): Q4 GAAP EPS of -$0.68. Cash, cash equivalents and marketable securities for the company as of December 31, 2021 were $81.8M compared to $5.0M at December 31, 2020. Based upon current operating plans, NexImmune expects that its existing cash, ca...
Clinical data updates for the Company’s two lead product candidates in Phase 1/2 clinical trials expected in 2H22 Investigational New Drug (IND) submission for NEXI-003, the Company’s first product for solid tumors, planned for 1H22 Plans to report additi...
NexImmune (NASDAQ:NEXI) announced the appointment of Kristi Jones as the company’s new Chief Executive Officer and a member of its Board of Directors effective, Feb. 15, following the resignation of former CEO Scott Carmer this week. Ms. Jones served as the company’s Chief Opera...
GAITHERSBURG, Md., Feb. 17, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today annou...
GAITHERSBURG, Md., Feb. 01, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today annou...
GAITHERSBURG, Md., Jan. 18, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today annou...
GAITHERSBURG, Md., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today annou...
Initial Phase 1/2 data presented at the 63 rd American Society of Hematology (ASH) Annual Meeting and Exposition Phase 1/2 study of NEXI-002 as a monotherapy in patients with relapsed/refractory multiple myeloma patients who have failed ≥3 prior lines of thera...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...